Department of Anesthesiology, University of Virginia, PO BOX 800710, Charlottesville, VA, 22908, USA.
Department of Neurosurgery, University of Virginia, PO BOX 800710, Charlottesville, VA, 22908, USA.
Curr Neurol Neurosci Rep. 2016 Oct;16(10):93. doi: 10.1007/s11910-016-0693-y.
Craniotomy pain may be severe and is often undertreated. Pain management following craniotomy is a balancing act of achieving adequate analgesia but avoiding sedation, respiratory depression, hypercapnia, nausea and vomiting, and hypertension. Opioids are a first-line analgesic therapy; however, concern that opioid-related adverse effects (sedation, respiratory depression) may interfere with neurologic assessment and increase intracranial pressure has limited use of these drugs for intracranial surgery. Non-opioid analgesics avoid these effects and may be useful as part of a multimodal regimen for post-craniotomy pain. Regional scalp blocks, paracetamol, and non-steroidal anti-inflammatory drugs are beneficial in the early post-operative period. Recent studies suggest a role for novel analgesics: dexmedetomidine, gabapentinoids, and ketamine, though additional studies are necessary.
开颅术后疼痛可能很剧烈,且往往治疗不足。开颅术后的疼痛管理是一个平衡的过程,既要达到足够的镇痛效果,又要避免镇静、呼吸抑制、高碳酸血症、恶心和呕吐以及高血压。阿片类药物是一线镇痛治疗药物;然而,由于担心阿片类药物相关的不良反应(镇静、呼吸抑制)可能会干扰神经学评估并增加颅内压,因此限制了这些药物在颅内手术中的应用。非阿片类镇痛药避免了这些影响,并且可以作为开颅术后疼痛多模式治疗方案的一部分发挥作用。局部头皮阻滞、对乙酰氨基酚和非甾体抗炎药在术后早期有益。最近的研究表明,新型镇痛药(右美托咪定、加巴喷丁类和氯胺酮)可能有作用,但还需要更多的研究。